Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
BQ-788 . sodium salt
220
CHF
CHF 220.00
In stock
AG-CP3-0012-C500500 µgCHF 220.00
AG-CP3-0012-M0011 mgCHF 290.00
Product Details | |
---|---|
Synonyms | ETB Receptor Antagonist; N-[(cis-2,6-Dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl-1-(methoxycarbonyl)-D-tryptophyl-D-norleucine |
Product Type | Chemical |
Properties | |
Formula |
C34H50N5O7 . Na |
MW | 640.8 . 23.0 |
CAS | 156161-89-6 |
Source/Host Chemicals | Synthetic. |
Purity Chemicals | ≥95% (HPLC) |
Appearance | White to off-white solid. |
Solubility | Soluble in DMSO, 0.1M sodium bicarbonate or 100% ethanol. Slightly soluble in methanol. Insoluble in water. |
InChi Key | QCVIFBRTTLMEOV-FUKQNADPSA-M |
Smiles | CCCC[C@@H](NC(=O)[C@@H](CC1=CN(C(=O)OC)C2=C1C=CC=C2)NC(=O)[C@H](CC(C)(C)C)NC(=O)N1[C@@H](C)CCC[C@H]1C)C(=O)O[Na] |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
Keep cool and dry. Protect from light. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Potent and selective endothelin B receptor (ETBR) antagonist.
Product References
- Clearance of circulating endothelin-1 by ETB receptors in rats: T. Fukuroda, et al.; BBRC 199, 1461 (1994)
- Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788: K. Ishikawa, et al.; PNAS 91, 4892 (1994)
- Novel antagonist of endothelin ETB1 and ETB2 receptors, BQ-788: effects on blood vessel and small intestine: H. Karaki, et al.; BBRC 205, 168 (1994)
- PD 142893, SB 209670, and BQ 788 selectively antagonize vascular endothelial versus vascular smooth muscle ET(B)-receptor activity in the rat: R.L. Schroeder, et al.; J. Cardiovasc. Pharmacol. 32, 935 (1998)
- BQ-788, a selective endothelin ETB receptor antagonist: M. Okada & M. Nishikibe; Cardiovasc. Drug Rev. 20, 53 (2002)